Establishment Labs Inc.
33.16
-0.55 (-1.63%)
At close: Jan 14, 2025, 3:59 PM
33.50
1.01%
Pre-market Jan 15, 2025, 04:00 AM EST
undefined%
Bid 33.5
Market Cap 953.94M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.59
PE Ratio (ttm) -12.81
Forward PE n/a
Analyst Buy
Ask 35
Volume 1,928,130
Avg. Volume (20D) 481,375
Open 34.86
Previous Close 33.71
Day's Range 31.14 - 36.42
52-Week Range 30.20 - 60.12
Beta undefined

About ESTA

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as dis...

Sector Healthcare
IPO Date Jul 19, 2018
Employees 908
Stock Exchange NASDAQ
Ticker Symbol ESTA

Analyst Forecast

According to 6 analyst ratings, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $62.5, which is an increase of 88.45% from the latest price.

Buy 83.33%
Hold 16.67%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Establishment Labs Inc. is scheduled to release its earnings on Feb 26, 2025, during market hours.
Analysts project revenue of $44.40M, reflecting a 40.68% YoY growth and earnings per share of -0.65, making a -17.72% decrease YoY.
1 day ago · Source
-26.38%
Establishment Labs shares are trading lower after ... Unlock content with Pro Subscription
2 months ago · Source
-1.41%
Establishment Labs shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 revenue guidance.